Zhang, Liyan
Fang, Yuan
Tan, Fangzhi
Guo, Fangfang
Zhang, Ziyu
Li, Nianci
Sun, Qiuhan
Qi, Jieyu
Chai, Renjie http://orcid.org/0000-0002-3885-543X
Funding for this research was provided by:
National Natural Science Foundation of China (82000984, 82030029, 81970882)
National Postdoctoral Program for Innovative Talents (BX20200082)
Natural Science Foundation of Jiangsu Province (BE2019711)
Shenzhen Fundamental Research Program (JCYJ20190814093401920, JCYJ20210324125608022)
National Key Research and Development Program of China (2020YFA0113600, 2020YFA0112503)
National Key Research and Development Program of China (2021YFA1101300)
Strategic Priority Research Program of the Chinese Academy of Science (XDA16010303)
China Postdoctoral Science Foundation (2020M681468)
Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University (SKLGE-2109)
Science and Technology Department of Sichuan Province (2021YFS0371)
Article History
Received: 3 November 2022
Revised: 15 February 2023
Accepted: 28 February 2023
First Online: 14 March 2023
Declarations
:
: Jieyu Qi had filed a patent on the use of AAV-ie for gene therapy in the inner ear. The authors declare no other competing interests.